Skip to main content
Elaine Shum, MD, Oncology, New York, NY

ElaineShumMD

Oncology • New York, NY

Hematologic Oncology, Thoracic Cancer

Thoracic Oncologist at NYU Langone Perlmutter Cancer Center

Join to view full profile

Dr. Shum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shum's full profile

Already have an account?

  • Office

    1000 10th Ave
    New York, NY 10019
    Phone+1 212-523-4000
    Fax+1 212-562-4036

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2014 - 2017
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2011 - 2014
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2011
  • Yale University
    Yale UniversityBS, Biology, 2002 - 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Lung Cancer Among Asian Americans: ‘It’s Okay to Ask’
    Lung Cancer Among Asian Americans: ‘It’s Okay to Ask’November 28th, 2020
  • Astra Zeneca Panel Addresses Lung Cancer Among Asian Americans
    Astra Zeneca Panel Addresses Lung Cancer Among Asian AmericansNovember 18th, 2020
  • Xencor Presents Updated Data from the DUET-2 Phase 1 Study of XmAb20717, PD-1 X CTLA-4 Bispecific Antibody, at the SITC Annual Meeting
    Xencor Presents Updated Data from the DUET-2 Phase 1 Study of XmAb20717, PD-1 X CTLA-4 Bispecific Antibody, at the SITC Annual MeetingNovember 9th, 2020
  • Join now to see all

Dr. Elaine Shum, Dr. Elaine Shum, MD, Dr. E Shum